Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Sorry to sound negative, but.....

RE: Sorry to sound negative, but.....

posted on Jun 26, 2006 10:08AM
I`m wondering if TPL/PTSC want to play things so close to the vest, we may not get any info on dividends this till quarter reporting.

Why?...well, in doing so, future divi rates can now be extrapolated from historical revenues payouts.

True, we`re introducing (assumed) share buybacks into the equation now, but I suspect (in judging Sr. Leckrone`s mindset) TPL wants absolutely no leaks, no numbers that will give any direct or indirect indicators of TPL`s recent revenue/licensing successes.

IMO this radio silence makes strategic sense.

JMHO, for entertainment purposes only.

Regards

Share
New Message
Please login to post a reply